Silicon as a Bioisostere for Carbon in Drug Design

In the pursuit of novel therapeutic agents, medicinal chemists often employ the concept of bioisosterism – the replacement of one atom or group in a molecule with another atom or group having similar physical or chemical properties. Silicon, due to its chemical similarity to carbon, has emerged as a fascinating bioisostere in drug design.

Silicon in Medicinal Chemistry

Silicon, located directly below carbon in the periodic table, shares many of its chemical properties but also offers distinct advantages as a bioisostere:

  1. Larger Atomic Radius: Silicon has a larger atomic radius than carbon, which can influence molecular shape and steric interactions.
  2. Increased Lipophilicity: Compounds with silicon may exhibit increased lipophilicity compared to their carbon analogs, potentially enhancing cell membrane permeability. See this case study for an illustration of this effect.
  3. Metabolic Stability: Silicon-containing compounds often show enhanced metabolic stability, which can be beneficial in extending the drug's effective half-life in the body.

Looking at a 3D model makes these differences obvious: the Si–C bonds in silafluofen are substantially longer than C–C bonds, which alters the shape of the molecule and the dihedral preferences of other bonds.

Applications of Silicon Bioisosteres

Silicon in Drug Candidates

Silicon has been used to replace carbon in various functional groups like alcohols, ketones, and amides. These modifications have resulted in compounds with altered pharmacokinetic and pharmacodynamic profiles, sometimes leading to improved therapeutic properties.

Case Studies

Several studies have demonstrated the potential of silicon bioisosteres. For instance, replacing a carbon atom with silicon in certain compounds has resulted in increased potency, selectivity, and metabolic stability. Here's some case studies:

There are lots more papers out there: see for instance this recent review.

Challenges in Silicon Bioisosterism

Despite its potential, the use of silicon as a bioisostere presents challenges:

  1. Synthetic Difficulty: Introducing silicon into organic molecules can be more challenging than traditional carbon-based synthesis. Nevertheless, more and more Si-containing building blocks are now available: see, for instance, this list from Enamine.
  2. Predicting Biological Effects: The effects of silicon substitution on biological systems are not always predictable, necessitating extensive testing.

Computational Chemistry and Silicon Bioisosteres

Advanced computational tools are crucial in predicting the effects of silicon substitution in drug molecules. Quantum chemistry, accessible through platforms like Rowan, can provide insights into the electronic structure, reactivity, and conformational changes resulting from silicon substitution. This predictive power is invaluable in the early stages of drug design. Computational studies also aid in understanding how silicon substitution impacts a drug's metabolism, helping to predict its pharmacokinetic behavior.

Conclusion

The use of silicon as a bioisostere for carbon in drug design is an area of growing interest. While challenges remain, the potential for developing novel therapeutics with improved properties is significant. Continued research, aided by computational chemistry tools like those offered by Rowan, is essential for advancing our understanding and application of silicon bioisosteres in medicinal chemistry.

For researchers interested in exploring the innovative realm of silicon bioisosteres, Rowan provides the computational platform necessary for such advanced studies. Begin your journey in pioneering drug design by creating an account at labs.rowansci.com/create-account.

Banner background image

What to Read Next

Studying Scaling in Electron-Affinity Predictions

Studying Scaling in Electron-Affinity Predictions

Testing low-cost computational methods to see if they get the expected scaling effects right.
Sep 10, 2025 · Corin Wagen
Open-Source Projects We Wish Existed

Open-Source Projects We Wish Existed

The lacunæ we've identified in computational chemistry and suggestions for future work.
Sep 9, 2025 · Corin Wagen, Jonathon Vandezande, and Ari Wagen
How to Make a Great Open-Source Scientific Project

How to Make a Great Open-Source Scientific Project

Guidelines for building great open-source scientific-software projects.
Sep 9, 2025 · Jonathon Vandezande
ML Models for Aqueous Solubility, NNP-Predicted Redox Potentials, and More

ML Models for Aqueous Solubility, NNP-Predicted Redox Potentials, and More

the promise & peril of solubility prediction; our approach and models; pH-dependent solubility; testing NNPs for redox potentials; benchmarking opt. methods + NNPs; an FSM case study; intern farewell
Sep 5, 2025 · Eli Mann, Corin Wagen, and Ari Wagen
Machine-Learning Methods for pH-Dependent Aqueous-Solubility Prediction

Machine-Learning Methods for pH-Dependent Aqueous-Solubility Prediction

Prediction of aqueous solubility for unseen organic molecules remains an outstanding and important challenge in computational drug design.
Sep 5, 2025 · Elias L. Mann, Corin C. Wagen
What Isaiah and Sawyer Learned This Summer

What Isaiah and Sawyer Learned This Summer

Reflections from our other two interns on their time at Rowan and what they learned.
Sep 5, 2025 · Isaiah Sippel and Sawyer VanZanten
Benchmarking OMol25-Trained Models on Experimental Reduction-Potential and Electron-Affinity Data

Benchmarking OMol25-Trained Models on Experimental Reduction-Potential and Electron-Affinity Data

We evaluate the ability of neural network potentials (NNPs) trained on OMol25 to predict experimental reduction-potential and electron-affinity values for a variety of main-group and organometallic species.
Sep 4, 2025 · Sawyer VanZanten, Corin C. Wagen
Which Optimizer Should You Use With NNPs?

Which Optimizer Should You Use With NNPs?

The results of optimizing 25 drug-like molecules with each combination of four optimizers (Sella, geomeTRIC, and ASE's implementations of FIRE and L-BFGS) and four NNPs (OrbMol, OMol25's eSEN Conserving Small, AIMNet2, and Egret-1) & GFN2-xTB.
Sep 4, 2025 · Ari Wagen and Corin Wagen
Double-Ended TS Search and the Invisible Work of Computer-Assisted Drug Design

Double-Ended TS Search and the Invisible Work of Computer-Assisted Drug Design

finding transition states; the freezing-string method; using Rowan to find cool transition states; discussing drug design
Sep 3, 2025 · Jonathon Vandezande, Ari Wagen, Spencer Schneider, and Corin Wagen
The Invisible Work of Computer-Assisted Drug Design

The Invisible Work of Computer-Assisted Drug Design

Everything that happens before the actual designing of drugs, and how Rowan tries to help.
Aug 28, 2025 · Corin Wagen